PlexusDx ensures patients receive fresh compounded semaglutide by coordinating delivery timing with your treatment schedule
The genetic insights generated through the Precision Peptide test inform whether semaglutide alone is ideal or whether dual-compound protocols like GLP-Squared Injection (semaglutide plus tirzepatide) may offer superior outcomes for your specific genetic architecture
In November 2024, the Centers for Medicare & Medicaid Services proposed rules that would extend anti-obesity drug benefits to 7.4 million beneficiaries, opening an untapped payer segment [2]Centers for Medicare & Medicaid Services, Proposal to Expand Access to Obesity Medications, cms.gov
In such circumstances, what other options are available to people
In the PWA model, with overt metabolic and gonadal perturbations, chronic intervention with GLP1/E or the triagonist markedly reduced body weight, food intake, and circulating leptin levels (Fig